Inclusion body myositis is an increasingly recognised form of inflammatory myopathy with characteristic clinical and histopatho-
N D Hopkinson, C Hunt, R J Powell, J Lowe Abstract Inclusion body myositis is an increasingly recognised form of inflammatory myopathy with characteristic clinical and histopathological features which has seldom been reported in the United Kingdom. This paper presents the clinicopathological features of a series of patients diagnosed in Nottingham from 1986 to 1990. During this period, 1319 muscle biopsy samples were processed by this laboratory and rimmed vacuoles were seen in 17 patients. Eleven patients had definite or probable inclusion body myositis according to published criteria. The mean age of the group was 69-4 years with a male to female ratio of 8:3. Typical clinical features were a slowly progressive painless, proximal lower limb weakness, with muscle wasting and early loss ofreflexes. The median duration ofillness from first symptom to presentation was five years (range 2-18 years). Fails were a prominent symptom in six patients and distal weakness occurred in nine patients. Creatine kinase was increased in 10 patients but only one had a level >1000 IU/l; the erythrocyte sedimentation rate was normal in five patients. Treat The term inclusion body myositis was first used by Yunis and Samaha' in 1971 when they described patients with a slowly progressive myopathy and characteristic nuclear and cytoplasmic filamentous inclusions accompanied by vacuoles rimmed by basophilic material in the muscle fibres (fig 1) . Electron microscopy of these 'rimmed' or 'lined' vacuoles showed that they contained cytoplasmic degradation products (fig 2) . These inclusions were originally observed by Chou2 in 1967 in a man with 'chronic polymyositis', and on electron microscopy he observed aggregates of interwoven filaments in the sarcoplasmic matrix (fig 3) which resembled myxovirus nucleocapsids. Since then inclusion body myositis has been increasingly recognised, Figure 2 Ultrastructurally, electron microscopy shows that the rimmed vacuoles correspond to vacuolation associated with autophagic debris forning membrane-like whorls (large arrow) adjacent to which is a filamentous inclusion bodv (small arrow). typically having an insidious onset after the age of 50 years, being more common in men, with the distal muscles often being affected, and a poor response to steroids.7 Most large series of patients with inclusion body myositis have been reported from the USA where, in one paper, it made up 28% of all cases of inflammatory myopathy, the most common cause after polymyositis (31%), and more common than dermatomyositis (18% Table 2 gives details of these 11 patients. Table  3 gives the clinical signs and results of investigations.
The mean age of this group was 69-4 years (range 60-81), with a male to female ratio of 8:3. The median duration of illness, from first symptom to diagnosis, was five years (range 2-18). The most common symptom was progressive muscle weakness, which occurred in 10/11 patients; the distribution of weakness is shown in table 3. All 10 patients with weakness had weakness of their legs, usually greater proximally. In contrast, only 8/10 had arm weakness, which in two patients was purely distal. Muscle wasting was apparent at presentation in all 10 patients with muscle weakness. Four patients had a loss of knee reflexes, and in a further three they were only present on reinforcement. Loss of ankle jerks was more common, these being completely lost in seven patients and present only on reinforcement in one patient.
Of the nine patients in whom the ESR was measured, four were abnormal (>20 mm/hour); the mean ESR was 23-9 mm/hour (range 2-74 mm/hour). One patient had a normal creatine kinase level and the highest value noted was 1187 IU/l (mean 633 IU/1). C reactive protein was normal in the four patients tested: three of nine patients had positive antinuclear antibodies, none in high titre. No patient had increased blood glucose. 1 ) are microtubular filaments on electron microscopy, proximal muscle weakness, and one other clinical criterion. These criteria would be satisfied by three previously reported patients who had a hereditary distal myopathy or oculopharyngeal muscular dystrophy.9 10 The main differences between the latter case reports and our own series are the patient's age and the family history of muscle disease. Our patients all presented when over 60 years old, whereas the patients with hereditary myopathy were 9, 22, and 23 years old at the time of their first symptom. Moreover, a family history of muscle disease was absent in the patients with inclusion body myositis. For probable inclusion body myositis, Calabrese et We did not characterise the mononuclear cell infiltrate in our patients; however, Arahata and Engel have previously reported that the predominantly endomysial inflammation in inclusion body myositis is composed of CD8+ T cells and macrophages in a 2:1 ratio. 17 Historically the involvement of viral agents, such as paramyxovirus, has been implicated. Two studies have provided other possible clues to the aetiology of this poorly understood disorder. Mendell et al'8 identified Congo red apple green birefringent deposits in vacuolated muscle fibres in inclusion body myositis characteristic of amyloid. The distribution of the amyloid collections corresponded to the typical filaments of inclusion body myositis. Furthermore, Askanas et al'9 have identified the type of amyloid as P-(A4) amyloid protein, which is central to the pathogenesis of Alzheimer's disease. This suggests that these j3-(A4) amyloid deposits in muscle in inclusion body myositis and the brain deposits in Alzheimer's disease may follow similar cellular events.
We conclude that inclusion body myositis does represent a distinct clinical and histopathological entity that is probably underdiagnosed in the United Kingdom. Evaluation of previous muscle biopsy or repeat biopsy samples are invaluable in the confirmation of the diagnosis and thereby targeting therapeutic approaches. Confirmation of the diagnosis relies on identification of often subtle features within the muscle biopsy sample and electron microscopy remains essential.
